Martin Mignot
Partner @ Index Ventures
London, United Kingdom
Martin Mignot is a Series A investor at Index Ventures in London focused on Software and SaaS. Martin Mignot is the Partner at Index Ventures.
- Total investments:
- 86
- Last investment:
- Lead investor:
- 41%
Last updated:
For AI agents: llms.txt
Industries Martin Mignot invests in
Stages Martin Mignot invests in
Countries Martin Mignot invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Series A
- $2.7M–$50M
- Series B
- $7.6M–$100M
- Series C
- $70M–$250M
Investment Focus
Industry
- Software 6 (7%)
- SaaS 5 (6%)
- Artificial Intelligence 5 (6%)
- FinTech 4 (5%)
- E-Commerce 4 (5%)
Stage
- Series A 18 (21%)
- Series B 18 (21%)
- Series C 15 (17%)
- Seed 11 (13%)
- Series D 6 (7%)
Country
- United States 15 (17%)
- France 9 (10%)
- United Kingdom 8 (9%)
- Germany 2 (2%)
- Sweden 1 (1%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Allara is a healthcare program that allows patients to access expert, specialty care through virtual appointments. Allara offers a medical provider and a registered dietitian for polycystic ovary syndrome. They provide holistic care, diagnostic testing, prescriptions, video appointments with a medical provider, dietary and lifestyle changes,nutrition counseling, and medication. | $30M / Venture - Series Unknown / Oct 13, 2026 | ||
| Oratomic develops neutral-atom quantum hardware and architectures for fault-tolerant quantum computing. The company focuses on utility-scale quantum computers that use light and atoms to implement ultra-efficient quantum error correction. Its work targets applications ranging from scientific discovery to new approaches in artificial intelligenceand complex simulation. Oratomic combines expertise in quantum error correction, neutral-atom platforms, optical engineering, and machine learning. The organization aims to make fully fault-tolerant quantum computing practical for real-world use cases. | $475M / Series B / Oct 08, 2026 | ||
| AI for the Built World. We accelerate the world’s most important projects from concept to completion and beyond. | $8.5M / Seed / Jun 30, 2026 | ||
| Nourish is a healthcare technology company that connects patients with registered dietitians through virtual nutrition counseling services covered by insurance plans. The platform allows users to find dietitians based on their health goals and attend appointments through telehealth, while also offering tools for meal tracking, goal monitoring, andnutrition guidance through its mobile application. Nourish works with registered dietitian nutritionists who provide support for conditions such as diabetes, weight management, cardiovascular health, eating disorders, and pediatric nutrition care. The company states that it partners with major insurance providers to reduce out-of-pocket costs for patients and offers ongoing nutritional care through recurring consultations. In addition to patient services, Nourish publishes educational resources and uses data-driven approaches to support personalized nutrition planning and long-term health management. | $100M / Series C / May 19, 2026 | ||
| Phaidra provides AI and ML solutions to accelerate performance in large-scale industries. | $50M / Series B / Oct 01, 2025 | ||
| Nourish is a healthcare technology company that connects patients with registered dietitians through virtual nutrition counseling services covered by insurance plans. The platform allows users to find dietitians based on their health goals and attend appointments through telehealth, while also offering tools for meal tracking, goal monitoring, andnutrition guidance through its mobile application. Nourish works with registered dietitian nutritionists who provide support for conditions such as diabetes, weight management, cardiovascular health, eating disorders, and pediatric nutrition care. The company states that it partners with major insurance providers to reduce out-of-pocket costs for patients and offers ongoing nutritional care through recurring consultations. In addition to patient services, Nourish publishes educational resources and uses data-driven approaches to support personalized nutrition planning and long-term health management. | $70M / Series B / Apr 23, 2025 | ||
| Dorsia is a members-only platform that offers reservations at in-demand restaurants in major cities. The platform utilizes technology to enhance experiences for both operators and members, ensuring smooth booking without stress. Dorsia operates in various cities, including Miami, Los Angeles, Dubai, and San Francisco, making it a versatile choicefor food enthusiasts. | $50.4M / Series A / Feb 14, 2025 | ||
| Allara is a healthcare program that allows patients to access expert, specialty care through virtual appointments. Allara offers a medical provider and a registered dietitian for polycystic ovary syndrome. They provide holistic care, diagnostic testing, prescriptions, video appointments with a medical provider, dietary and lifestyle changes,nutrition counseling, and medication. | $26M / Series B / Jan 24, 2025 | ||
| Jump provides a secure environment for freelancers to work and allows them to optimize their remuneration. The company was founded in 2020 and is headquartered in Paris, Ile-de-France, France. | $12.2M / Series A / Sep 23, 2024 | ||
| Cowboy is an e-bike company that creates innovative electric bikes for city riders. It is still transforming the bike and mobility industries, from the point of sale to the point of service. Its mission is to empower riders to map their own paths, as well as the paths of the cities in which they live, through mindful movement that benefitseveryone.Cowboy's electric bikes are simple — there is no gear and no + and - buttons to adjust the motor's power. The company believes riding a bike should be as simple as hopping into the saddle and putting one foot on the peddle. | $4.4M / Venture - Series Unknown / Sep 04, 2024 | ||
| See all 86 investments → | |||
Co-Investors
About Index Ventures
Index Ventures is a venture capital company that provides investment capital and strategic support to early-stage and growth-stage technology enterprises across sectors such as software, fintech, healthcare, and consumer services. It engages with entrepreneurial teams to assess business models, support scaling efforts, and provide guidance through successive development phases. The company’s services include sourcing investment opportunities, conducting due diligence, structuring financing deals, and offering ongoing advisory interactions with portfolio founders. Index Ventures also maintains a network of industry relationships and resources aimed at facilitating connections between founders, investors, and market opportunities. Its focus spans from initial seed rounds through later financing stages to help portfolio companies pursue expansion and market entry efforts.
Index Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Georgia Stevenson
Partner
|
|||
Gerald Rimer
Team Member
|
|||
Hannah Seal
Principal/Partner
|
|||
Jan Hammer
Investor & Partner
|
|||
Julia Andre
Principal/Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Martin Mignot invest in?
Martin Mignot invests primarily in Software, SaaS and Artificial Intelligence startups, most often at Series A and Series B stage. Most of the 86 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Martin Mignot invest in?
Martin Mignot typically joins rounds of $2.7M–$50M at Series A, $7.6M–$100M at Series B and $70M–$250M at Series C. These are whole funding-round sizes, not Martin Mignot's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Martin Mignot took part in.
How do I contact Martin Mignot?
Public channels for Martin Mignot include LinkedIn and X (Twitter). For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Martin Mignot last invest?
The most recent investment recorded for Martin Mignot closed in Oct 2026. Shizune tracks 86 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
